Tuesday 16 November 2021

• 15:00 - Clinical Validation of a Soluble TCR Bispecific Platform: Emerging Lessons from Tebentafusp Development
  Dr Mohammed Dar (Immunocore)
  Oxford-Immunocore seminar series